business models

Trusts quizzed to become digital excellence centres

26 NHS Trusts will be entered and 16 awarded up to £10 million in order to become ‘centres of global digital excellence’.

As the money will be allocated based on the progress of digital strategies already in place within the Trusts and not on need, there is a danger that the digital divide will soon include hospital Trusts.

Article here

First patient facing app to get GP system approval

iPatient expects to get approval to integrate with a GP primary system sometime soon. The system enables patients to view their health records and test results, book appointments, use secure messaging, and request repeat prescriptions.

It has taken years of development to get to this point, with pilots in five GP practices using the Emis Health primary system.

Full article here:

August 8th, 2016|Regulation|0 Comments|
  • Permalink Gallery

    Hub and Spoke Dispensing: Privacy and Sociotechnical Rigidity

Hub and Spoke Dispensing: Privacy and Sociotechnical Rigidity

In a previous post, we noted how a hub and spoke model for community pharmacy had been promoted on the basis of a limited safety case. The hub and spoke model that was described was one in which items would be assembled at a hub site that would serve a number of dispensing sites, such as community pharmacies. Although […]

  • Permalink Gallery

    Hub and Spoke Dispensing: Safety and Sociotechnical Pliability

Hub and Spoke Dispensing: Safety and Sociotechnical Pliability

Over the course of the last year, the Department of Health has looked at the use of hub and spoke dispensing systems for community pharmacy in England, a technology which some view as an inevitable extension of electronic prescription transmission in primary care. In a hub and spoke system, medicines required for a primary care prescription are put together […]

Google and Patient Data

Further to our blog post last week, Google is now being investigated by the data protection watchdog: the Information Commissioner’s Office (ICO) over it’s data deal between the Royal Free Hospital Trust and DeepMind.

The investigation results from ‘at least’ one complaint received over the anonymising of data. While the Hospital Trust declare that all data is anonymised in transit and […]

Testing & Mental Health Apps

In a recent article, Nature raises concerns that ‘the technology is moving a lot faster than the science’ and many of the apps designed and marketed to help with mental health care are simply not tested. This leaves customer-patients vulnerable to apps which, at best, don’t work and could make their condition worse.

 

Of course, these apps do many things: some […]

April 25th, 2016|Regulation|0 Comments|

Old drugs for new uses

Researchers at the University of Leeds are using: the anti-psychotic haloperidol; the anti-depressant fluoxetine and a local anaesthetic bupivacainein as anti-virals.

The drugs disrupt the regulation of potassium levels and this, in turn, blocks the ability of all of the group of bunyaviruses to infect cells. It’s not effective on all viruses, but is looking very promising research.

Full article here.

Crowdacure, 3D Holograms and Phantom Limb Pain

Crowdacure is an interesting new website. A crowd sourcing site for underfunded and hard to fund medical research, one of the first projects is developing a new treatment using 3D holograms to relieve phantom limb pain.

Visual effects can trick the brain into believing that the lost limb is still there, resulting in pain relief.

3D printing of drugs: “the possibilities seem endless”

The possibilities do seem endless, but the Guardian asks whether the 3D printing of medications is safe. They speculate how the pharmacies might change if drugs were printed in local pharmacies, to exact and personalized formulations. The FDA has already given the go-ahead for Spritam levetiracetam (a drug used to control epilepsy) and the hope is to follow with […]

Printing Digital Drugs

The Guardian reports on 3D printing drugs. The FDA (US Food & Drug Administration) has approved the printing of a pill containing a new drug, Spritam levetiracetam, (to control epileptic seizures). There are a number of universities across the world working on applying this technology to drugs, hoping to make it safer and more tailored to individual patients.

Full article […]